Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1-year double-blinded placebo-controlled randomized clinical trial,Journal of Periodontology

当前位置： X-MOL 学术 › J. Periodontol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1-year double-blinded placebo-controlled randomized clinical trial
Journal of Periodontology ( IF 4.2 ) Pub Date : 2022-07-23 , DOI: 10.1002/jper.21-0171
Marcelo Faveri ₁ , Belen Retamal-Valdes ₁ , Maria Josefa Mestnik ₁ , Luciene Cristina de Figueiredo ₁ , Valentim Adelino Ricardo Barão ₂ , João Gabriel Silva Souza _{1,

3} , Poliana Mendes Duarte _{1,

4} , Magda Feres _{1,

5}

Affiliation

Despite the body of evidence supporting the clinical benefits of metronidazole (MTZ) and amoxicillin (AMX) in the treatment of young patients with periodontitis, the microbiological outcomes of this antibiotic protocol have been less explored. This study evaluated the microbiological effects of adjunctive MTZ+AMX in the treatment of young patients with periodontitis.

中文翻译：

阿莫西林联合甲硝唑治疗年轻 III 期和 IV 期牙周炎患者的微生物学效应：来自 1 年双盲安慰剂对照随机临床试验的二次分析

尽管有大量证据支持甲硝唑 (MTZ) 和阿莫西林 (AMX) 在治疗年轻牙周炎患者方面的临床益处，但对该抗生素方案的微生物学结果的研究较少。本研究评估了 MTZ+AMX 辅助治疗年轻牙周炎患者的微生物学效果。

更新日期：2022-07-23

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11